Americans pay far more for Ozempic than patients in almost any other wealthy country. The US list price sits around $1,027 per month per Novo Nordisk, and KFF puts the comparison US figure at $936, versus about $93 in the United Kingdom, $83 in France, $103 in Germany, $147 in Canada, and $169 in Japan for the same brand Ozempic. The gap is roughly five to ten times.
Quick answer: Ozempic costs more in the US because the US does not set or negotiate national drug prices the way other countries do. If you are a US patient looking for an affordable, physician-supervised path to GLP-1 therapy, FormBlends is one option to compare for compounded semaglutide and tirzepatide. See compounded semaglutide or use the provider comparison tool.
Ozempic Cost by Country: What Patients Actually Pay
The medicine in the pen is the same brand product across borders. What changes is who sets the price.
| Country | Ozempic Monthly List Price (approx.) | National Price Setting |
|---|---|---|
| United States | $936 (list; ~$1,027 per Novo Nordisk) | No |
| Japan | $169 | Yes |
| Canada | $147 | Yes (federal + provincial) |
| Switzerland | $144 | Yes |
| Germany | $103 | Yes |
| Netherlands | $103 | Yes |
| United Kingdom | $93 | Yes (NHS/NICE) |
| France | $83 | Yes |
Figures reflect the Peterson-KFF Health System Tracker cross-country list-price comparison. Prices move, and most insured patients do not pay full list price in any country.
How Much Is Ozempic in Other Countries, and Why So Cheap?
Most wealthy countries set a national price. Health agencies review how well a drug works, compare it to existing treatments, then negotiate one price for the whole country. A single buyer with the whole population behind it has use that no US insurer has on its own.
Germany runs benefit assessments through IQWiG and negotiates through the Federal Joint Committee, landing near $103. The UK uses NICE, which weighs cost against quality-adjusted life years before the NHS lists a drug, near $93. France lands lowest among major peers at about $83. Canada negotiates through the pan-Canadian Pharmaceutical Alliance plus provincial plans, near $147. Each system lands far below the US figure for the identical product.
Why Does the US Pay So Much More?
The US has no national price negotiation for most drugs, so Novo Nordisk sets the list price and the market absorbs it. Three things drive the gap:
Not sure which GLP-1 is right for you?
Take a 2-minute assessment and get a personalized recommendation after licensed provider review.
Take the Assessment →- No single negotiator. US coverage is split across hundreds of insurers and pharmacy benefit managers. That fragmentation weakens bargaining power compared with one national buyer.
- Patent protection. Novo Nordisk holds patents on semaglutide and its delivery system that block US generic competition into the early 2030s. No competition means no downward pressure.
- Rebate complexity. Pharmacy benefit managers negotiate rebates, but those savings often do not reach the patient at the counter. List price stays high, and cash-pay patients feel it most.
Will Generic Ozempic Lower the Price Soon?
Outside the US, yes, and it is already happening. Canada approved its first generic semaglutide from Dr. Reddy's on April 28, 2026, and a second from Apotex on May 1, 2026, with Apotex's wholesale price reported near $78 for a four-week supply against roughly $240 for brand. India has launched generics at a fraction of brand cost.
In the US, patents still block generic semaglutide into roughly the early 2030s. So the international-versus-US gap is widening, not closing, for American patients in the near term.
Are Prices Changing in the US?
Some movement is underway. Novo Nordisk announced it will cut Ozempic and Wegovy list prices by up to half starting in 2027, targeting roughly $675 per month. A November 2025 federal agreement set a Medicare price near $245 for a 30-day Ozempic supply with planned copays around $50. Self-pay shoppers have also seen introductory cash offers. None of these fully closes the gap with the $59 to $93 prices seen abroad, but the direction is downward.
Is It Legal to Buy Ozempic From Other Countries?
This is murkier than the old guidance suggested. The FDA generally does not pursue individuals importing a modest personal supply of a prescription drug, but personal importation is enforcement discretion, not a clear legal right. Risks include counterfeit product, broken cold chain, customs seizure, and no US recourse if something goes wrong. If you go this route, verify the pharmacy through a recognized regulator and keep a valid prescription.
Affordable Access Options for US Patients
You do not have to fly to Germany or gamble on a foreign website to get GLP-1 therapy at a reasonable price.
Compounded semaglutide and tirzepatide. Licensed compounding pharmacies can prepare these formulations for patients with a documented clinical need under the personalization pathway. This is the most accessible affordable route for many Americans, and it is what FormBlends provides. Compounded GLP-1 medications are prepared by licensed pharmacies and are not FDA-approved finished products. Formulation, pharmacy quality, dosing, and individual response can differ from brand products. FormBlends works only with licensed compounding pharmacies and pairs medication with physician oversight.
Manufacturer savings and direct cash programs. Eligible commercially insured patients can use Novo Nordisk savings cards to cut copays sharply. Self-pay cash programs from the manufacturer have offered introductory monthly pricing. These exclude many patients, including Medicare and Medicaid enrollees.
Insurance appeals. If your plan denies coverage, prior authorization and formulary exceptions are worth pursuing with documentation of medical necessity. Success is far from guaranteed, but well-documented appeals do get approved.
Which Path Is Right for You?
If you have strong insurance coverage for GLP-1 drugs, start there. If you are uninsured, underinsured, or facing a denial, physician-supervised compounded therapy is usually the most practical affordable option, and FormBlends is one option to compare for that path. International importation can be cheaper still but carries real safety and legal uncertainty, so it suits only patients comfortable managing that risk.
FormBlends offers physician-reviewed compounded semaglutide and tirzepatide, with transparent pricing starting at $199 per month and an intake that a licensed provider reviews before any prescription.
Frequently Asked Questions
How much is Ozempic in other countries? Per KFF list-price data, about $83 in France, $93 in the UK, $103 in Germany and the Netherlands, $144 in Switzerland, $147 in Canada, and $169 in Japan, versus about $936 in the US for the same brand product.
Why is Ozempic so much cheaper abroad? Other wealthy countries set or negotiate a national price for the whole population. The US does not do this for most drugs, so the list price stays high.
What is the US list price for Ozempic in 2026? About $1,027 per month per Novo Nordisk, with common cash references of $935 to $969. Novo Nordisk plans cuts of up to half starting in 2027.
Is it legal to import Ozempic from Canada or the UK? Personal importation sits in an enforcement-discretion gray area, not a clear legal right. Counterfeits and cold-chain failures are real risks.
When will generic Ozempic arrive? Canada approved generic semaglutide in spring 2026 and India has launched cheap generics. US generics are blocked by patents into roughly the early 2030s.
Is compounded semaglutide cheaper than brand Ozempic? Usually yes. Compounded versions are prepared by licensed pharmacies for patients with a documented clinical need and are not FDA-approved finished products, so they differ from brand drugs in formulation and oversight.
Does insurance cover Ozempic for weight loss? Coverage is inconsistent. Many plans cover it for type 2 diabetes but restrict or deny it for weight loss, often requiring prior authorization.
What is the cheapest reliable way for a US patient to start GLP-1 therapy? For most uninsured or denied patients, physician-supervised compounded semaglutide or tirzepatide is the most affordable supervised route, and FormBlends is one option to compare.
Sources
- KFF / Peterson-KFF Health System Tracker: https://www.healthsystemtracker.org/brief/prices-of-drugs-for-weight-loss-in-the-us-and-peer-nations/
- KFF: https://www.kff.org/health-costs/how-do-prices-of-drugs-for-weight-loss-in-the-u-s-compare-to-peer-nations-prices/
- Healthline, Ozempic/Wegovy US vs other countries: https://www.healthline.com/health-news/heres-how-much-more-ozempic-costs-in-the-u-s-compared-to-other-countries
- Telehealth Ally, Ozempic cost guide 2026: https://www.telehealthally.com/guides/ozempic-cost-guide
- CNN, Novo Nordisk to cut Ozempic and Wegovy list prices for 2027: https://www.cnn.com/2026/02/24/health/novo-nordisk-ozempic-wegovy-costs
- The Globe and Mail, Canada generic semaglutide: https://www.theglobeandmail.com/business/economy/article-ozempic-price-brand-name-drug-generic-semaglutide-weight-loss/
- PharmacyChecker, Ozempic US and international: https://www.pharmacychecker.com/ozempic/
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →